Log in to save to my catalogue

Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective

Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10459149

Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective

About this item

Full title

Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective

Publisher

Basel: MDPI AG

Journal title

Polymers, 2023-08, Vol.15 (16), p.3354

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

With the success of several clinical trials of products based on human serum albumin (HSA) and the rapid development of nanotechnology, HSA-based nanodrug delivery systems (HBNDSs) have received extensive attention in the field of nanomedicine. However, there is still a lack of comprehensive reviews exploring the broader scope of HBNDSs in biomedic...

Alternative Titles

Full title

Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10459149

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10459149

Other Identifiers

ISSN

2073-4360

E-ISSN

2073-4360

DOI

10.3390/polym15163354

How to access this item